Related Experiment Video
Updated: May 20, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
MicroRNA-125b-1 accelerates a C-terminal mutant of C/EBPα (C/EBPα-C(m))-induced myeloid leukemia
Yutaka Enomoto1, Jiro Kitaura, Masaya Shimanuki
1Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
Abstract:
MicroRNA-125b-1 (miR-125b-1) is a target of the chromosomal translocations t(11;14)(q24;q32) and t(2;11)(p21;q23), which are found in human B-lymphoid and myeloid malignancies, respectively. These translocations result in overexpression of mature miR-125b, consisting of 22 nucleotides. To analyze the role of miR-125b-1 in leukemogenesis, we created a bone marrow transplantation model using a retrovirus vector containing GFP expression elements. Sole transduction of miR-125b-1 into bone marrow cells resulted in expansion of hematopoietic cells expressing GFP. Compared with cells lacking GFP expression, we observed that GFP(+)/CD11b(+) or GFP(+)/Gr(-)1(+) cells were increased in the bone marrow and spleen. Although previous studies reported sole induction of miR-125b-induced leukemia, we did not find leukemic transformation in our model. Transduction of miR-125b-1 did accelerate myeloid tumors induced by a C-terminal mutant of CAAT-enhancer binding protein (C/EBPα-C(m)), a class II-like mutation. As miR-125b has been shown to hasten the development of leukemia in a BCR/ABL-transduced animal model, our present results support the conclusion that overexpression of miR-125b cooperates with other genetic alterations in the pathogenesis of myeloid malignancies.
Insights
MicroRNA-125b-1 (miR-125b-1) overexpression expands hematopoietic cells but does not solely cause leukemia. However, it accelerates myeloid tumor development when cooperating with other genetic mutations.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNA-125b-1 (miR-125b-1) is implicated in B-lymphoid and myeloid malignancies due to chromosomal translocations.
- These translocations lead to the overexpression of mature miR-125b.
Purpose of the Study:
- To investigate the role of miR-125b-1 in leukemogenesis.
- To determine if miR-125b-1 alone can induce leukemia or if it cooperates with other genetic factors.
Main Methods:
- A bone marrow transplantation model was established using a retrovirus vector with GFP expression elements.
- Bone marrow cells were transduced with miR-125b-1 to assess its effects on hematopoietic cell expansion and tumor development.
Main Results:
- Sole transduction of miR-125b-1 led to the expansion of hematopoietic cells, specifically GFP(+)/CD11b(+) and GFP(+)/Gr(-)1(+) populations in bone marrow and spleen.
- Leukemic transformation was not observed with miR-125b-1 transduction alone.
- miR-125b-1 accelerated myeloid tumors induced by a mutant CAAT-enhancer binding protein (C/EBPα-C(m)).
Conclusions:
- Overexpression of miR-125b-1 does not solely induce leukemia but contributes to hematopoietic cell expansion.
- miR-125b-1 cooperates with other genetic alterations, such as C/EBPα-C(m), in the pathogenesis of myeloid malignancies.
- These findings support the role of miR-125b-1 as a cooperating factor in myeloid leukemogenesis.
Related Concept Videos
MicroRNAs
MicroRNAs
Master Transcription Regulators
Induced Pluripotent Stem Cells
Somatic cells are...

